Results 181 to 190 of about 150,968 (195)

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1999
Intrinsic and/or acquired resistance to chemotherapy is the major obstacle to overcome in the treatment of patients with ovarian carcinoma. The aim of the present study was to investigate the prognostic value of drug resistance-associated proteins P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), canalicular multispecific organic
Arts, H. J., Katsaros, D., de Vries, E. G., Massobrio, M., Genta, F., Danese, S., Arisio, R., Scheper, R. J., Kool, M., Scheffer, G. L., Willemse, P. H., van der Zee, A. G., Suurmeijer, A. J.   +12 more
openaire   +3 more sources

[Studies on multidrug resistance associated protein in retinoblastoma].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2010
To detect the expression of P-glycoprotein (P-gp), lung resistance associated protein (LRP) and multidrug resistance associated protein (MRP) in retinoblastoma (Rb), to analyze the relationship between the expression of multidrug resistant (MDR) markers with clinic-pathological factors, the correlations among these three markers, and to study the ...
Bin, Li, Rui, Gao, Hao, Zhang, Liao-qing, Li, Fei, Gao, Ruo-jin, Ren   +5 more
openaire   +1 more source

Multidrug Resistance-Associated Protein: Sequence Correction

Science, 1993
S P, Cole, R G, Deeley
openaire   +2 more sources

Drug resistance caused by multidrug resistance-associated proteins.

Novartis Foundation symposium, 2002
Three types of drug efflux pumps, the multidrug resistance gene 1 (MDR1 or ABCB1)-encoded P glycoprotein, the multidrug resistance-associated protein (MRP or ABCC1) and breast cancer resistance protein (BCRP or ABCG2) may play an important part in the intrinsic or acquired defence of cells against drugs.
openaire   +1 more source

Biology of the multidrug resistance-associated protein, MRP

European Journal of Cancer, 1996
D W, Loe, R G, Deeley, S P, Cole
openaire   +2 more sources

Mistletoe lectin binds to multidrug resistance-associated protein MRP5.

Anticancer research, 2010
Mistletoe lectins (MLs) are the active components of aqueous mistletoe extracts widely used in complementary cancer therapy, however, it is not clear if they bind to carbohydrate residues only or whether they interact with proteins as well. Protein-protein interactions do not seem unlikely as MLs act at very low molar concentrations usually observed ...
Nina, Nehmann, Ulrika M, Schade, Uwe, Pfüller, Melitta, Schachner, Udo, Schumacher   +4 more
openaire   +1 more source

„Multidrug resistance-associated proteins“ beim malignen Melanom

Der Hautarzt, 2009
A.F. Wendel, C. Skazik, H.F. Merk, J.M. Baron   +3 more
openaire   +1 more source

ABC Transporters: Multidrug Resistance-Associated Proteins

2021
openaire   +1 more source

Multidrug Resistance-Associated Protein 1

2020
openaire   +1 more source

P-Glycoprotein, Multidrug-Resistance-Associated Protein and Parkinson’s Disease

European Neurology, 2001
D G, Le Couteur, M W, Davis, M, Webb, P G, Board   +3 more
openaire   +2 more sources